Utah Medical Products, Inc. (UTMD) - EV/EBITDA Multiple
Utah Medical Products (UTMD) produces specialized medical equipment while facing risks from global logistics and trade tariffs. This price chart shows that Utah Medical Products (UTMD) shares demonstrate an EV/EBITDA ratio of 9.96, while the company relies on a loyal staff of development engineers. High ISO standards and patent protection, combined with long-term contracts with clinics, create significant barriers to entry for new market players.
Analytical breakdowns for utahmed.com (UTMD)
- stock price and consensus target price:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Utah Medical Products|UTMD - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Utah Medical Products, Inc.|UTMD - Aggregate Debt Obligations|Debt to Book Value Utah Med|UTMD - Company Long-Term Debts|Company Short-Term Debt Utah Medical Products|Quick Ratio utahmed.com
- business earnings and investment ratios data:
UTMD - Company Net Income|Expected Profit Utah Medical Products|UTMD - Price to Earnings Multiple|Projected Price to Earnings Utah Medical Products|UTMD - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Utah Med|UTMD - Operating income before deduction of amortization|Net earnings per share for the last 12 months Utah Medical Products|UTMD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months utahmed.com|UTMD - Net earnings per one share growth for the current year|Earnings growth forecast for next year Utah Medical Products
- sales and revenue indicators:
Summary company analysis:Utah Medical (UTMD)
The ultra-conservative approach of Utah Medical Products management toward debt management makes the company's historical EV/EBITDA chart a benchmark for financial stability. This ratio correlates the total enterprise value with its operating profit before interest and taxes. Low values indicate an undervalued asset, while sharp peaks signal overpayment. It is critical for the investor to see the stability of the curve as confirmation of margin protection.
Competitors of Utah Medical Products
Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|KRMD (korumedical.com) - Enterprise Value to EBITDA Ratio|Nyxoah S.A (NYXH) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MBOT|PDEX (pro-dex.com) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ZTEK|EV/EBITDA Multiple Elutia Inc (ELUT)|EV/EBITDA Multiple MLSS (Milestone Scientific Corp)|Business Value to Operating Income Before Depreciation NXGL|RVP: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation HBIO (Harvard Bioscience Inc.)|Femasys (FEMY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Meihua Medical Technologies Co., Ltd.|POAI (Predictive Oncology Inc) - EV/EBITDA Multiple|Company Value to EBITDA Callan JMB Corp CJMB|EV/EBITDA Multiple ATRI|neurometrix.com - Enterprise Value to Operating Income Before Depreciation
